US Nucleic Acid Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

US Nucleic Acid Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • August 2016 •
  • 1157 pages •
  • Report ID: 4109170

Highlights

  • Comprehensive 1,157-page market segmentation analysis of the US NAT market.
  • Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:
                 - Infectious Diseases
                 - Cancer
                 - Forensic Testing
                 - Genetic Diseases
                 - Paternity Testing/HLA Typing

  • Review of testing methodologies and instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,157 pages and 65 tables

Industry=Pathology ParentIndustry=LifeSciences Date=201608 Publisher=VenturePlanningGroup Price=6000